Ausgabe Sonderheft 4/2025 Use of 177Lu prostate-specific membrane antigen therapy inmetastatic castration-resistant prostate cancer
Inhalt (1 Artikel)
Use of 177Lu prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer
- Open Access
- Consensus report
Siroos Mirzaei, Gregor Schweighofer-Zwink, Heidemarie Ofner, Jasmin Bektic, Harun Fajkovic, Eisabeth von Guggenberg, Anton Ponholzer, Gero Kramer, Lukas Lusuardi, Michael Gabriel, Tatjana Traub-Weidinger, Marcus Hacker, Shahrokh F. Shariat
